MX9306998A - A THERAPEUTIC COMPOSITION OF TANDOSPIRONE AND A DOSAGE FORM TO ADMINISTER IT. - Google Patents

A THERAPEUTIC COMPOSITION OF TANDOSPIRONE AND A DOSAGE FORM TO ADMINISTER IT.

Info

Publication number
MX9306998A
MX9306998A MX9306998A MX9306998A MX9306998A MX 9306998 A MX9306998 A MX 9306998A MX 9306998 A MX9306998 A MX 9306998A MX 9306998 A MX9306998 A MX 9306998A MX 9306998 A MX9306998 A MX 9306998A
Authority
MX
Mexico
Prior art keywords
administer
dosage form
tandospirone
therapeutic composition
patient
Prior art date
Application number
MX9306998A
Other languages
Spanish (es)
Inventor
Atul D Ayer
Dana Ridzon
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/010,086 external-priority patent/US5330762A/en
Application filed by Alza Corp filed Critical Alza Corp
Publication of MX9306998A publication Critical patent/MX9306998A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se provee una forma de dosis para administrar un fármaco de la fórmula:(ver fórmula I) a un paciente para producir un beneficio ansiolítico en elpaciente.A dosage form is provided to administer a drug of the formula: (see formula I) to a patient to produce an anxiolytic benefit in the patient.

MX9306998A 1993-01-27 1993-10-08 A THERAPEUTIC COMPOSITION OF TANDOSPIRONE AND A DOSAGE FORM TO ADMINISTER IT. MX9306998A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/010,086 US5330762A (en) 1992-02-27 1993-01-27 Tandospiaine antidepressive therapy
PCT/US1993/009627 WO1994016699A1 (en) 1993-01-27 1993-10-08 Compositions containing tandospirone or its analogs

Publications (1)

Publication Number Publication Date
MX9306998A true MX9306998A (en) 1995-01-31

Family

ID=26680762

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9306998A MX9306998A (en) 1993-01-27 1993-10-08 A THERAPEUTIC COMPOSITION OF TANDOSPIRONE AND A DOSAGE FORM TO ADMINISTER IT.

Country Status (1)

Country Link
MX (1) MX9306998A (en)

Similar Documents

Publication Publication Date Title
FI920956A0 (en) DOSERINGSFORM FOER ADMINISTRERING AV ORAL HYPOGLYKEMISK GLIPISID.
ES2139132T3 (en) PHARMACEUTICAL COMPOSITIONS ACTIVE IN SLEEP DISORDERS THERAPY.
GEP20063799B (en) Tropane derivatives useful in therapy
DE60143911D1 (en) ANTITUMOR COMPOSITIONS CONTAINING ECTEINASCIDINE 743
ES2194210T3 (en) DOSAGE FORM TO SUPPLY AN ASCENDING DOSAGE OF PHARMACO.
MY132705A (en) Novel compounds with analgesic effect
MX9203443A (en) A DOSAGE FORM FOR THE DELAYED DELIVERY OF A PHARMACY.
CY1112753T1 (en) HUMAN BODY CANCER TREATMENT BY USE TO743
MX9307885A (en) APPLICATION OF CARBAMZAEPINE AND OXCARBAZEPIAN TO OBTAIN MEDICINES FOR THE TREATMENT OF PARKINSON DISEASE AND PARKINSONIAN SYNDROMES.
AR019053A1 (en) USE OF 2'2'-DIFLUORONUCLEOSIDS FOR THE PREPARATION OF A PHARMACEUTICAL MEDICINAL PRODUCT AND COMPOSITION AND PHARMACEUTICAL PRODUCT CONTAINING THEM
ES2130152T3 (en) MEDICINES TO TREAT INFLAMMATORY PAIN OR ANALGESIA CONTAINING A NSAID AND RANITIDINE / BISMUTE CITRATE.
YU42397A (en) Using raloxiphene for medicine preparation
AR037524A1 (en) DOSAGE UNIT INCLUDING A PROSTAGLANDINE ANALOG FOR THE CONSTIPATION TREATMENT
DE60115432D1 (en) APOPTOTIC BODIES FOR USE IN THE TREATMENT OF T-CELL MEDICAMENT AND INFLAMMATORY DISEASES
ES2054333T3 (en) DOSAGE FORM TO ADMINISTER A CALCIUM ANTAGONIST.
MX9304365A (en) AN OSMOTIC DOSAGE FORM FOR ADMINISTERING TANDOSPIRONE.
UY26595A1 (en) LOW DOSE USE USE FORMULATIONS
DK1478362T3 (en) Combination therapy for acute myocardial infarction
MX9306998A (en) A THERAPEUTIC COMPOSITION OF TANDOSPIRONE AND A DOSAGE FORM TO ADMINISTER IT.
ATE298240T1 (en) SEPARATE DOSE THERAPIES WITH VASCULAR DAMAGED ACTIVITY
HUP9802005A2 (en) Use of sodium-hydrogen-exchange-inhibitors for producing pharmaceutical compositions for reducing the cardiotoxic effect of some substances
CO5170404A1 (en) MELANOMAS THERAPY
RU94000695A (en) Agent showing antiallergic action
EA200101157A1 (en) 14β-H-STEROLS CONTAINING THEIR PHARMACEUTICAL COMPOSITIONS AND THE APPLICATION OF THESE DERIVATIVES FOR THE PREPARATION OF MEDICINES OF REGULATING MEIOSE
ES2062752T3 (en) PREPARED FROM AN OXYPURINOL SALT IN ORAL FORM FOR THE TREATMENT OF HYPERURICEMIA.